Abstracts tagged "sarcoidosis and tumor necrosis factor (TNF)"

Abstract Number: 2127 • ACR/ARHP Annual Meeting 2017
Tumor Necrosis Factor Inhibitors for Sarcoidosis
Stefanie Wade¹ and Mollie Carruthers², ¹Medicine, University of Connecticut Health Center, Farmington, CT, ²Rheumatology, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Patients with sarcoidosis refractory to standard treatment are a therapeutic challenge and are often managed by a variety of specialists due to the heterogeneity…
Abstract Number: 1397 • ACR/ARHP Annual Meeting 2015
Successful Treatment of Cardiac Sarcoidosis with Biologic and Immunosuppressive Combination Therapy
Maya Estephan¹, Mehrdad Maz², Mark Hamblin³ and Julian Magadan¹, ¹Division of Allergy, Clinical Immunology, and Rheumatology, University of Kansas Medical Center, Kansas City, KS, ²Division of Rheumatology, University of Kansas Medical Center, Kansas City, KS, ³Pulmonary and Critical Care Medicine, ILD Clinic, University of Kansas Medical Center, Kansas city, KS
Background/Purpose: Although cardiac involvement is symptomatic in only 5% of patients with sarcoidosis, it is considered an important prognostic factor and the second leading cause…